NDC 83703-088 – Flucelvax
Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL; Influenza A Virus A/victoria/800/2024… · Injection, Suspension · Intramuscular
Product NDC83703-088
Product details
- Brand name
- Flucelvax
- Generic name
- INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- Labeler
- Bamboo US BidCo LLC
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Marketing category
- BLA · BLA125408
- Marketed since
- August 1, 2026
- Listing expires
- December 31, 2027
Active ingredients
- Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
- Influenza A Virus A/victoria/800/2024 Cvr-289 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
- Influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 83703-088-03 | 10 SYRINGE, GLASS in 1 CARTON (83703-088-03) / .5 mL in 1 SYRINGE, GLASS (83703-088-04) | Aug 1, 2026 |
Other Flucelvax products
- 87063-299 Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck… · Injection, Suspension · ASCLEMED USA INC.
- 70461-656 Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck… · Injection, Suspension · Seqirus Inc.
- 85766-263 Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck… · Injection, Suspension · Sportpharm LLC